Yes, $1s is what people are saying if the trial failed, but that doesn't seem likely at all given that CytoDyn and the FDA look to be cooperating with each other from all I can see.
>> More likely what we'll see is not a completely bombed trial, but a missed primary endpoint but some secondary endpoints that were met. <<
I don't think so.
Short interest down 6 million shares to 21,610,017 from 27,620,396 as of 2/12/2021 -
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.